Allergy Immunotherapy Market By Type Of Allergy (Food Allergy, Allergic Rhinitis, Skin Allergy, Insect-Bite Allergy, Other Allergies), By Type Of Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) ) - Growth, Future Prospects, And Competitive Landscape, 2018 - 2026

Industry Outlook

The allergy immunotherapy market had a market value of US$ 1,499.0 million in 2017 and was expected to grow at a CAGR of 10.1% between 2018 and 2026. Allergy immunotherapy helps to prevent or minimize allergic reactions and provides a long-term benefits to patients. This therapy helps to increase immunological tolerance and changes the course of the disease, due to which the demand for immunotherapy is increasing globally.

Market Synopsis

Subcutaneous immunotherapy (SCIT) is a popular treatment for allergic rhinitis and asthma because it provides patients with long-term relief.

SCIT is an effective therapy against allergic diseases as it delivers symptomatic relief by altering the effect of an allergic reaction by focusing on the basic mechanisms of immunology. Thus, in 2017, SCIT was identified as the largest allergy immunotherapy type that is preferred and adopted by most physicians. In addition to that, compared with conventional treatment, the cost-effectiveness of SCIT is high, and new molecules under the trial will assist in the overall growth of allergy immunotherapy.

Air pollution has increased due to infrastructural development and industrialization in China and India, specifically assisting the growth of asthma and allergic rhinitis.

The Asia Pacific region is the fastest-growing segment, owing to key driving factors such as rising prevalence and awareness of allergic conditions, as well as increased air pollution in China and India as a result of industrialization and infrastructure development. According to the World Health Organization (WHO), there has been a significant growth in the prevalence of allergic rhinitis in Asia–Pacific within the last decade, which has increased the economic burden. According to experts, the key factors responsible for the sudden growth in allergic rhinitis are the changing environment, improvements in hygiene and reduced infections, and increasing cases of genetic complications.

Historical and Future Period

The allergy immunotherapy market was analyzed considering current market trends for the base year of 2017, and based on future trends, CAGRs were calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on the allergy immunotherapy market provides an in-depth analysis with quantitative and qualitative data points related to the major market dynamics (opportunities, drivers, and restraints) affecting or assisting the market, as well as regional trends and further sub-segmented markets by country. Extensive information on the global allergy immunotherapy market is provided in the report by segmenting the market based on the type of allergy, treatment, and geography. The major objective of publishing this research report is to assist the companies operating in this market in designing and implementing strategies in the allergy immunotherapy market.

This report also covers segments, including data specific to major market trends, opportunities, drivers, and restraints, to gain precise information about the global allergy immunotherapy market. The key market players analyzed in the report are based on major attributes such as business strength, product portfolio, and important market strategies. The report also covers an attractive investment proposition based on the in-depth geographical research executed based on PESTEL analysis. The companies profiled in the report are Hollister Stier, Leti, WOLW Pharma, Aimmune Therapeutics, ALK-Abello A/S, Stallergenes Greer, Allergopharma, DVB Technologies, Allergy Therapeutics, Biomay AG, HAL Allergy Group, Circassia, and Merck KGaA, among others.

Key questions are answered in this report.

  • Which is the trending allergy type in the market and why?
  • What are the recent market strategies adopted and implemented by key companies present in the allergy immunotherapy market?
  • Which are the most attractive markets (regions and countries) that are prominent and rapidly growing throughout the forecast period in the allergy immunotherapy market?
  • Which is the largest and fastest-growing allergy immunotherapy treatment globally?
  • Which are the major treatments contributing to the overall growth of allergy immunotherapy in the near future?
  • What is the competitive environment in the allergy immunotherapy market, and what are the strategies of major companies in this industry?

Frequently Asked Questions:

The market for Allergy Immunotherapy Market is expected to reach At US$ 1,499.0 Mn in 2026

The Allergy Immunotherapy Market is expected to see significant CAGR growth over the coming years, at 10.1%.

The report is forecasted to 2018-2026

The base year of this report is 2017.

ALK-Abello A/S,HAL Allergy Group,Circassia,Aimmune Therapeutics,Merck KGaA are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Apr 2019
Category:  Pharmaceuticals
Report ID:   59655
Report Format:   PDF
Pages:   120
Rating:    4.2 (49)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support